litlas
Log inCreate account

Éric Vivier

Active 1991–2026

Also published as
Eric Vivier
227
Papers
57,485
Citations
124
h-index
223
i10-index

Citations

Citations per year for Éric Vivier1990: 1 citations1991: 4 citations1992: 10 citations1993: 15 citations1994: 20 citations1995: 42 citations1996: 56 citations1997: 142 citations1998: 164 citations1999: 146 citations2000: 127 citations2001: 143 citations2002: 190 citations2003: 175 citations2004: 207 citations2005: 236 citations2006: 251 citations2007: 287 citations2008: 414 citations2009: 400 citations2010: 432 citations2011: 464 citations2012: 503 citations2013: 622 citations2014: 708 citations2015: 741 citations2016: 607 citations2017: 652 citations2018: 627 citations2019: 2,356 citations2020: 2,851 citations2021: 2,831 citations2022: 2,375 citations2023: 1,743 citations2024: 2,505 citations2025: 1,362 citations2026: 21 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,173 citing papers, 25.4% of this breakdownChina: 3,317 citing papers, 13.7% of this breakdownFrance: 1,588 citing papers, 6.5% of this breakdownGermany: 1,478 citing papers, 6.1% of this breakdownUnited Kingdom: 1,389 citing papers, 5.7% of this breakdownItaly: 1,145 citing papers, 4.7% of this breakdownJapan: 762 citing papers, 3.1% of this breakdownCanada: 740 citing papers, 3.1% of this breakdownAustralia: 667 citing papers, 2.8% of this breakdownNetherlands: 587 citing papers, 2.4% of this breakdownSpain: 507 citing papers, 2.1% of this breakdownSwitzerland: 486 citing papers, 2% of this breakdown
0%25.4%Other 22.4%

Institutions

Fields

  • Immunology and Microbiology50%
  • Medicine27.2%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Neuroscience2.4%
  • Engineering1.2%
  • Agricultural and Biological Sciences0.5%
  • Other1.3%

Topics

  • Immune Cell Function and Interaction15.5%
  • T-cell and B-cell Immunology6.8%
  • CAR-T cell therapy research4.2%
  • IL-33, ST2, and ILC Pathways4.2%
  • Immunotherapy and Immune Responses4.1%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Other61.3%

Coauthors

All papers

Open in search
  1. Innate Lymphoid Cells: 10 Years On

    Authors: Éric Vivier, David Artis, Marco Colonna, Andreas Diefenbach, James P. Di Santo, Gérard Eberl, Shigeo Koyasu, Richard M. Locksley, Andrew N. J. McKenzie, Reina E. Mebius, Fiona Powrie, Hergen Spits - Cell 2018 cited by 2,128

  2. Functions of natural killer cells

    Authors: Éric Vivier, Elena Tomasello, Myriam Baratin, Thierry Walzer, Sophie Ugolini - Nature Immunology 2008 cited by 3,836

  3. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

    Authors: Sophie Viaud, Fabiana Saccheri, Grégoire Mignot, Takahiro Yamazaki, Romain Daillère, Dalil Hannani, David Enot, Christina Pfirschke, Camilla Engblom, Mikaël J. Pittet, Andreas Schlitzer, Florent Ginhoux, Lionel Apétoh, Élisabeth Chachaty, Paul‐Louis Woerther, Gérard Eberl, M Bérard, Chantal Ecobichon, Dominique Clermont, Chantal Bizet, Valérie Gaboriau‐Routhiau, Nadine Cerf–Bensussan, Paule Opolon, Nadia Yessaad, Éric Vivier, Bernhard Ryffel, Charles O. Elson, Joël Doré, Guido Kroemer, Patricia Lepage, Ivo G. Boneca, François Ghiringhelli, Laurence Zitvogel - Science 2013 cited by 2,027

  4. Harnessing innate immunity in cancer therapy

    Authors: Olivier Demaria, Stéphanie Cornen, Marc Daëron, Yannis Morel, Ruslan Medzhitov, Éric Vivier - Nature 2019 cited by 952

  5. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

    Authors: Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel, Benjamín Rossi, Romain Remark, Violette Breso, Elodie Bonnet, Guillaume Habif, Sophie Guia, Ana I. Lalanne, Caroline Hoffmann, Olivier Lantz, Jérôme Fayette, Agnès Boyer-Chammard, Robert Zerbib, P. Dodion, Hormas Ghadially, Maria Jure‐Kunkel, Yannis Morel, Ronald Herbst, Émilie Narni-Mancinelli, Roger B. Cohen, Éric Vivier - Cell 2018 cited by 1,212

  6. Innate or Adaptive Immunity? The Example of Natural Killer Cells

    Authors: Éric Vivier, David H. Raulet, Alessandro Moretta, Michael A. Caligiuri, Laurence Zitvogel, Lewis L. Lanier, Wayne M. Yokoyama, Sophie Ugolini - Science 2011 cited by 2,757

  7. Natural killer cell therapies

    Authors: Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, Stéphanie Cornen, Rob Igarashi, Valeria R. Fantin - Nature 2024 cited by 419

  8. Tumor-Infiltrating Natural Killer Cells

    Authors: Beatriz Cózar, Marco Greppi, Sabrina Carpentier, Émilie Narni-Mancinelli, Laura Chiossone, Éric Vivier - Cancer Discovery 2020 cited by 469

  9. Innate lymphoid cells — a proposal for uniform nomenclature

    Authors: Hergen Spits, David Artis, Marco Colonna, Andreas Diefenbach, James P. Di Santo, Gérard Eberl, Shigeo Koyasu, Richard M. Locksley, Andrew N. J. McKenzie, Reina E. Mebius, Fiona Powrie, Éric Vivier - Nature reviews. Immunology 2013 cited by 2,309

  10. Natural killer cells and other innate lymphoid cells in cancer

    Authors: Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, Éric Vivier - Nature reviews. Immunology 2018 cited by 1,008

  11. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

    Authors: Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli, Séverine Augier, Aurélie Docquier, Laurent Gros, Rachel Courtois, Cécile Déjou, Diana Jecko, O. Becquart, Hélène Rispaud-Blanc, Laurent Gauthier, Benjamín Rossi, Stéphanie Chanteux, Nicolas Gourdin, Béatrice Amigues, Alain Roussel, Armand Bensussan, Jean‐François Eliaou, Jérémy Bastid, François Romagné, Yannis Morel, Émilie Narni-Mancinelli, Éric Vivier, Carine Paturel, Nathalie Bonnefoy - Cell Reports 2019 cited by 416

  12. New immune cell engagers for cancer immunotherapy

    Authors: Aurore Fenis, Olivier Demaria, Laurent Gauthier, Éric Vivier, Émilie Narni-Mancinelli - Nature reviews. Immunology 2024 cited by 178

  13. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

    Authors: Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald, Susanna S. Ng, Arabella Young, Shin Foong Ngiow, Jai Rautela, Jasmin Straube, Nicola Waddell, Stephen J. Blake, Juming Yan, Laurent Bartholin, Jason S. Lee, Éric Vivier, Kazuyoshi Takeda, Meriem Messaoudene, Laurence Zitvogel, Michele W.L. Teng, Gabrielle T. Belz, Christian Engwerda, Nicholas D. Huntington, Kyohei Nakamura, Michael Hölzel, Mark J. Smyth - Nature Immunology 2017 cited by 640

  14. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells

    Authors: Antoine Marçais, Julien Cherfils‐Vicini, Charlotte Viant, Sophie Degouve, Sébastien Viel, Aurore Fenis, Jessica Rabilloud, Katia Mayol, Armelle Tavares, Jacques Bienvenu, Yann‐Gaël Gangloff, Éric Gilson, Éric Vivier, Thierry Walzer - Nature Immunology 2014 cited by 602

  15. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

    Authors: Laurent Gauthier, Ariane Morel, Nadia Anceriz, Benjamín Rossi, Audrey Blanchard-Alvarez, Gwendoline Grondin, Sylvia Trichard, Cédric Cesari, Melody Sapet, Frédéric Bosco, Hélène Rispaud-Blanc, Franceline Guillot, Stéphanie Cornen, Alain Roussel, Béatrice Amigues, Guillaume Habif, Flavien Caraguel, Sandrine Arrufat, Romain Remark, François Romagné, Yannis Morel, Émilie Narni-Mancinelli, Éric Vivier - Cell 2019 cited by 427

  16. High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice

    Authors: Adeline Crinier, Pierre Milpied, Bertrand Escalière, Christelle Pipéroglou, Justine Galluso, Anaïs Balsamo, Lionel Spinelli, Iñaki Cervera-Marzal, Mikaël Ebbo, Mathilde Girard-Madoux, Sébastien Jaeger, Emilie Bollon, Sami Hamed, Jean Hardwigsen, Sophie Ugolini, Fréderic Vély, Émilie Narni-Mancinelli, Éric Vivier - Immunity 2018 cited by 465

  17. High-dimensional single-cell analysis of human natural killer cell heterogeneity

    Authors: Lucas Rebuffet, Janine Melsen, Bertrand Escalière, Daniela Basurto-Lozada, Avinash Bhandoola, Niklas K. Björkström, Yenan T. Bryceson, Roberta Castriconi, Frank Cichocki, Marco Colonna, Daniel M. Davis, Andreas Diefenbach, Yi Ding, Muzlifah Haniffa, Amir Horowitz, Lewis L. Lanier, Karl‐Johan Malmberg, Jeffrey S. Miller, Lorenzo Moretta, Émilie Narni-Mancinelli, Luke O'neill, Chiara Romagnani, Dylan G. Ryan, Simona Sivori, Dan Sun, Constance Vagne, Éric Vivier - Nature Immunology 2024 cited by 228

  18. Maturation of mouse NK cells is a 4-stage developmental program

    Authors: Laura Chiossone, Julie Chaix, Nicolas Fuséri, Claude Roth, Éric Vivier, Thierry Walzer - Blood 2009 cited by 766

  19. SnapShot: Natural Killer Cells

    Authors: Adeline Crinier, Émilie Narni-Mancinelli, Sophie Ugolini, Éric Vivier - Cell 2020 cited by 235

  20. A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment

    Authors: Arabella Young, Shin Foong Ngiow, Yulong Gao, Ann‐Marie Patch, Deborah S. Barkauskas, Meriem Messaoudene, Gene Lin, Jérôme D. Coudert, Kimberley Stannard, Laurence Zitvogel, Mariapia A. Degli‐Esposti, Éric Vivier, Nicola Waddell, Joel Linden, Nicholas D. Huntington, Fernando Souza-Fonseca-Guimarães, Mark J. Smyth - Cancer Research 2017 cited by 380

  21. Monalizumab: inhibiting the novel immune checkpoint NKG2A

    Authors: Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Émilie Narni-Mancinelli, Sjoerd H. van der Burg, Éric Vivier - Journal for ImmunoTherapy of Cancer 2019 cited by 285

  22. Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

    Authors: Nicolas Jacquelot, Cyril Seillet, Minyu Wang, Angela Pizzolla, Yang Liao, Soroor Hediyeh-zadeh, Sharon Grisaru‐Tal, Cynthia Louis, Qiutong Huang, Jaring Schreuder, Fernando Souza-Fonseca-Guimarães, Carolyn A. de Graaf, Kevin Thia, Sean Macdonald, Mary Camilleri, Kylie Luong, Shengbo Zhang, Michaël Chopin, Tristan Molden-Hauer, Stephen L. Nutt, Viktor Umansky, Bogoljub Ćirić, Joanna R. Groom, Paul S. Foster, Philip M. Hansbro, Andrew N. J. McKenzie, Daniel H.D. Gray, Andreas Behren, Jonathan Cebon, Éric Vivier, Ian P. Wicks, Joseph A. Trapani, Ariel Munitz, Melissa J. Davis, Wei Shi, Paul J. Neeson, Gabrielle T. Belz - Nature Immunology 2021 cited by 175

  23. Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

    Authors: Laurent Gauthier, Angéla Virone-Oddos, Jochen Beninga, Benjamín Rossi, Céline Nicolazzi, Céline Amara, Audrey Blanchard-Alvarez, Nicolas Gourdin, Jacqueline Courta, Alexandra Basset, Magali Agnel, Franceline Guillot, Gwendoline Grondin, Hélène Bonnevaux, Anne-Laure Bauchet, Ariane Morel, Yannis Morel, Marielle Chiron, Éric Vivier - Nature Biotechnology 2023 cited by 100

  24. Natural Killer Cell Signaling Pathways

    Authors: Éric Vivier, Jacques A. Nunès, Frédéric Vely - Science 2004 cited by 740